No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Case-Control Studies
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Female
-
Genetic Association Studies
-
Genetic Predisposition to Disease
-
Humans
-
Lymphoma, Follicular / diagnosis*
-
Lymphoma, Follicular / drug therapy
-
Lymphoma, Follicular / genetics*
-
Lymphoma, Follicular / mortality
-
Male
-
Middle Aged
-
Polymorphism, Single Nucleotide*
-
Prednisone / therapeutic use
-
Prognosis
-
Rituximab
-
Survival Analysis
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / genetics*
-
Vincristine / therapeutic use
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
R-CHOP protocol
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone